Iron hydroxide polymaltose--cause of persistent iron deficiency anemia at delivery.
Indian J Med Sci
;
2001 Nov; 55(11): 616-20
Artigo
em Inglês
| IMSEAR
| ID: sea-69316
ABSTRACT
Ironhydroxide polymaltose (IPC) preparations were used to treat four pregnant women with iron deficiency anemia. Despite patient compliance for sufficient length of time, hemoglobin failed to rise. By the time this was noticed, pregnancy was well advanced and delivery was only few weeks away. Patients were switched over to ferrous fumarate/succinate/parenteral iron. Although hemoglobin increased, women were still iron deficient at the time of delivery. Besides exposing women to hazards of iron deficiency at the time of delivery, their new borns are exposed to the risks intrauterine growth retardation and its consequences in childhood and later life. It would be advisable to avoid the use IPC preparations in patients with iron deficiency anemia, especially pregnant women.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Complicações Hematológicas na Gravidez
/
Feminino
/
Humanos
/
Gravidez
/
Compostos Férricos
/
Falha de Tratamento
/
Anemia Ferropriva
/
Adulto
/
Hematínicos
Idioma:
Inglês
Revista:
Indian J Med Sci
Ano de publicação:
2001
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS